Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 4Melanoma 3Breast Neoplasms 3Urogenital Neoplasms 2Stomach Neoplasms 2Sarcoma 2Ovarian Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Head and Neck Neoplasms 2Neoplasm Metastasis 1Inflammation 1Fatigue 1Cognitive Dysfunction 1Brain Neoplasms 1Behavior 1

Interventions

Surveys and Questionnaires 5Counseling 3Motivational Interviewing 2Interviews as Topic 2College Fraternities and Sororities 2Transportation 1Spermine Synthase 1Risk Factors 1Risk Assessment 1Riluzole 1Price Transparency 1Precision Medicine 1Palliative Care 1Methods 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1House Calls 1Exercise 1Ethanol 1Educational Status 1Decision Support Techniques 1Cannabidiol 1Blood Specimen Collection 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Behavior × Riluzole × Clear all
NCT02796755 2021-04-14

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Emory University

Phase 4 Completed
30 enrolled 10 charts

Behavior, Fatigue, Inflammation, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡